Moreover, their early-phase insulin secretion tended to decrease and second-phase insulin secretion elevated significantly in vivo. This phenomenon is also commonly observed in patients with IGT (impaired glucose tolerance) or early-stage T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.